Physician and patient preferences for dosing options in migraine prevention

The Journal of Headache and Pain

Robert Cowan¹  Erik Rosenman²  Ravi Iyer³  Joshua M. Cohen³ 

[1] Department of Neurology and Neuroscience, Stanford University School of Medicine, Stanford, Los Angeles, CA, USA;Healthcare Strategy Partners LLC, Eldersburg, Baltimore, MD, USA;Teva Pharmaceuticals, Frazer, Philadelphia, PA, USA;

关键词: CGRP antibody;    Dosing preference;    Dosing flexibility;    Therapy adherence;    Migraine prevention;    Monthly dosing;    Quarterly dosing;   

DOI  :  10.1186/s10194-019-0998-8

来源: Springer

【 摘 要 】

BackgroundAdherence to a therapy, though a key factor for successful treatment, is low among patients with chronic conditions such as migraine. Dose frequency plays a major role in adherence. This study evaluated the impact of having flexible dosing options on acceptance of and adherence to a new migraine preventive therapy class among adults with migraine.MethodsIn this observational study, two 20-min online surveys were completed: one by physicians currently treating adult patients with migraine and the other by adults with migraine. Both surveys presented the participants with three scenarios: 1) only monthly, 2) only quarterly, and 3) both dosing options of the new medication are available. Physicians estimated the proportion of their migraine patients who would receive the new medication in each scenario. Patients were asked about their dosing preference when either or both options are available. Respondents were asked to rate the likelihood of their acceptance of and adherence to the therapy.Results400 physicians and 417 US adults with migraine completed the surveys. The availability of both dosing options yielded a significant increase in the proportion of patients expected to receive the new medication. The overall proportion of patients favoring monthly dosing (35%) was similar to the proportion favoring quarterly dosing (40%). Among those who preferred monthly dosing (n = 147), a greater proportion indicated they are more likely to fill the prescription (77% vs 56%, P < 0.05) and remain adherent (80% vs 57%, P < 0.05) when only monthly is available versus when only quarterly is available. Similarly, among those who preferred quarterly dosing (n = 166), a greater proportion indicated they are likely to fill (63% vs 55%, P < 0.05) and remain adherent (62% vs 54%, P < 0.05) when only quarterly is available compared with when only monthly is available.ConclusionsPhysicians anticipated that the proportion of patients to receive the new medication would increase when both dosing options are available. Patients stated that they are more likely to fill the prescription and adhere to the new therapy when their preferred dosing regimen is available.

【 授权许可】

CC BY